We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Gold Supplier
25-OH Vitamin D Control
Complete D
Gold Supplier
COVID-19 Nucleic Acid Releaser (For PCR)
Nucleic Acid Releaser (For PCR)
Silver Supplier
Flock Tipped Applicator
HydraFlock 6" Sterile Large Flock Swab w/Polystyrene Handle, 80mm Breakpoint
Silver Supplier
Disposable Viral Preservation Tube
Disposable Viral Preservation Tube
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
22 May 2021 - 26 May 2021
Virtual Venue
25 May 2021 - 28 May 2021

Molecular Diagnostics

Image: Photograph of the novel capsule-based smell test (Photo courtesy of Queen Mary University of London)

A Novel Capsule-Based Smell Test for Diagnosis of Neurological and Respiratory Diseases

To aid in diagnosing diseases where loss of the sense of smell is a symptom, such as in chronic neurological conditions like Parkinson's and Alzheimer's diseases and in acute respiratory infections such as that caused by COVID-19, a team of researchers at Queen Mary University of London (United Kingdom) developed a novel smell testing kit based on capsules of aromatic oils placed between two strips of single-sided tape. More...
10 May 2021
Image: The Hamamatsu Photonics Nanozoomer 1 Digital Slide Scanner (Photo courtesy of University of Adelaide)

Genetic Background and Clinicopathologic Features Established for Adult-Onset Nephronophthisis

Nephronophthisis (NPH) is a genetic disorder of the kidneys which mainly affects children. It is classified as a medullary cystic kidney disease. The disorder is inherited in an autosomal recessive fashion and, although rare, is the most common genetic cause of childhood kidney failure. More...
06 May 2021
BIOHIT  Healthcare OY
Image: The AMPLIX real-time polymerase chain reaction system (Photo courtesy of Biosynex)

LAMP Assay Developed to Diagnose High HBV DNA Levels

Worldwide, 257 million people are chronically infected with hepatitis B virus (HBV) and 887,000 annually die from cirrhosis or liver cancer. Since more than 95% of HBV-infected people live in low-income and middle-income countries (LMICs) and only 12-25% of infected people are eligible for anti-HBV therapy. More...
05 May 2021
Image: EN2: a novel prostate cancer biomarker (Photo courtesy of Future Medicine)

Protein Biomarker Increases Sensitivity of a Urine-based Prostate Cancer Test

A team of British researchers increased the sensitivity of an advanced RNA and DNA biomarker-based urine test for diagnosis of aggressive prostate cancer by including the measurement of a protein biomarker, which is expected to reduce the number of unnecessary biopsies performed every year by up to 35%. More...
05 May 2021
Image: Micrograph of a colorectal adenocarcinoma metastasis to a lymph node. The cancer (forming glands) is seen at the center-top. Adipose tissue is present on the upper right (Photo courtesy of Wikimedia Commons)

Blood-based Liquid Biopsy Detects Lymph Node Metastasis in Colorectal Cancer Patients

A recent paper described a novel, noninvasive liquid biopsy test for detection of lymph node metastasis in individuals with high-risk T1 colorectal cancer. More...
04 May 2021
Mayo Medical Laboratories
Image: The Oncotype DX Genomic Prostate Score (GPS) test is a strong independent predictor of prostate cancer-specific death and disease progression (metastases) at 10 years in men with localized prostate cancer (Photo courtesy of Genomic Health)

GPS Assay Associated with Long-Term Prostate Cancer Outcomes

Long-term cancer outcomes are an important consideration when deciding between active surveillance (AS) and immediate treatment for newly diagnosed prostate cancer. Multiple prospective AS studies that predominantly include patients at the lowest risk of progression have demonstrated a low risk of distant metastasis (DM) and prostate cancer–specific mortality (PCSM) with extended follow-up. More...
03 May 2021
Image: A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle (Photo courtesy of Wikimedia Commons)

A Rapid Metabolomic Test for Early Diagnosis of Myocardial Infarction

A metabolomic platform with GC/MS (gas chromatography–mass spectrometry) and LC/MS (liquid chromatography–mass spectrometry) instrumentation has been developed to profile plasma metabolites of patients with chest pain for early detection of myocardial infarction (MI). More...
03 May 2021

Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2021 Globetech Media. All rights reserved.